Update of the COVID-19 vaccine: In approving the maximum expected COVID-19 vaccine, the Indian Medical Research Council (ICMR) said Tuesday that the vaccine of 3 applicants who oppose Indian coronavirus is at other stages of clinical trials, PTI reported.
Dr. Balram Bhargava, executive director of ICMR, said that lately there are 3 Indian coVID-19 vaccine applicants who are in other stages of clinical trials. The Director-General of the Medical Research Council of India said that among the 3 applicants, Phase 1 trials for the Bharat Biotech vaccine and the Zydus Cadila DNA vaccine were completed. Phase 2 will begin now.
With respect to the third, the Oxford vaccine, manufactured through the Serum Institute of India, added that it obtained approval for Phase 2 and 3 clinical trials, and those trials will begin in a week at 17 sites across the country.
Previously, the Comptroller General of Medicines of India (DCGI) approved the complex level of clinical trials of the COVID-19 vaccine jointly developed through the University of Oxford and AstraZeneca in India. DCGI has approved the Serum Institute of India (SII) for Phases II and III of human clinical trials. IBS supports Oxford-AstraZeneca in the progression of the COVID-19 vaccine, PTI reported.
According to the approval, clinical trials of the COVID-19 candidate vaccine had been reported throughout India. Under the revised proposal, up to 1,600 people over the age of 18 are expected to participate in clinical trials in 17 decided centres.
PTI had indicated that the tests would be conducted at AIIMS Delhi, AIIMS-Jodhpur, Andhra Medical College in Visakhapatnam, Postgraduate Institute of Education and Medical Research in Chandigarh, BJ Medical College in Pune, Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in Patna, Nehru Hospital in Gorakhpur and JSS Academy of Higher Education and Research.
SII collaborated with AstraZeneca to manufacture the Oxford vaccine and submitted an application to DCGI on 25 July for approval for testing. Globally, the vaccine is in phase III and phase III trials in the United Kingdom; Phase III trials in Brazil and phase I and II trials in South Africa.
Get live equity costs from BSE, NSE, U.S. market. And the latest liquidity value, mutual fund portfolio, calculate your taxes, the source of the income tax calculator, meet the most productive winners on the market, the most productive losers and the most productive equity funds. Like it on Facebook and stay with us on Twitter.
Financial Express is now on Telegram. Click here to register on our channel and stay up to date with the latest News and Updates from Biz.